CurrentEndo
Get Weekly

Topic · page 35 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 1,361–1,400 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

  1. Diabetes Care

    International Variation in Case Fatality After Major Coronary or Cerebrovascular Events in Individuals With Type 2 Diabetes: Evidence From ADVANCE, TECOS, and EXSCEL

    Meta-analysis

  2. Diabetes Metab

    Prevalence and predictive factors of computed tomography-detected pancreatopathy in a cohort of adult patients hospitalized for newly diagnosed or uncontrolled non-auto-immune diabetes

    Cohort study

  3. Diabetes Obes Metab

    Efficacy and safety benefits of HR17031 , a fixed‐ratio combination of INS068 and noiiglutide, versus its components alone in Chinese patients with type 2 diabetes uncontrolled on oral antidiabetic drug(s): A phase 2, multicentre, open‐label, randomised, parallel three‐arm, treat‐to‐target trial

    Randomized controlled trial

  4. Diabetes Obes Metab

    Social determinants of health and progression to cardio–renal–metabolic multimorbidity and mortality in people with prediabetes: A prospective cohort study

    Cohort study

  5. Diabetes Obes Metab

    Impact of glucagon‐like peptide‐1 receptor agonists on the incidence of inflammatory bowel disease in people with type 2 diabetes

    Cohort study

  6. Diabetes Care

    Analysis of Long-term Follow-up of a Randomized Clinical Trial With Departures From Assigned Treatments: Estimation of Metformin Effects on Diabetes and Its Complications in the Diabetes Prevention Program Outcomes Study

    Secondary analysis

  7. Diabetes Care

    Longitudinal Metabolic Trajectories in Diabetes Prevention Program Participants Reveal Subgroups With Varying Micro- and Macrovascular Complication Risks

    Secondary analysis

  8. Int J Obes (Lond)

    The relationship between plasma sphingosine-1-phosphate, plasma apolipoprotein M, obesity, and the risk of incident type 2 diabetes: a prospective cohort study

    Cohort study

  9. Ann Intern Med

    Comparison of an Energy-Reduced Mediterranean Diet and Physical Activity Versus an Ad Libitum Mediterranean Diet in the Prevention of Type 2 Diabetes : A Secondary Analysis of a Randomized Controlled Trial

    Secondary analysis

  10. Diabetes Res Clin Pract

    Periodontitis, accelerated biological aging, and advanced stages in cardiovascular-kidney-metabolic syndrome in U.S. Adults: A mediation analysis

    Cross-sectional study

  11. Diabetes Res Clin Pract

    Untangling the role of diet quality and other risk factors in the severity of metabolic syndrome: Insights from the Hoveyzeh Cohort study using structural equation modeling

    Cross-sectional study

  12. Diabetes Care

    Prediction of Sarcopenia Onset in Type 2 Diabetes Using Urinary Titin Levels: A Japanese Prospective Cohort Study

    Cohort study

  13. Cardiovasc Diabetol

    Atherogenic index of plasma and its 5-year changes associated with type 2 diabetes risk: a 10-Year cohort study

    Cohort study

  14. J Clin Endocrinol Metab

    Genetic and Clinical Characteristics of Monogenic Diabetes in Japan: A Nationwide Study by the Japan Diabetes Society

    Cross-sectional study

  15. J Diabetes Sci Technol

    Smartphone Application-Based Rehabilitation Program for Older Adults With Type 2 Diabetes Mellitus: Insights From the Design, Development, and Validation

    Diagnostic or prognostic study

  16. Osteoporos Int

    Increased fall risk in people with type 2 diabetes and cardiovascular disease: a systematic review and meta-analysis

    Meta-analysis

  17. Cardiovasc Diabetol

    Impact of changes in conventional risk factors induced by once-weekly GLP-1 receptor agonist exenatide on cardiovascular outcomes: an EXSCEL post hoc analysis

    Secondary analysis

  18. Diabetes Res Clin Pract

    Bedtime sliding scale insulin is unnecessary for hospitalized patients with bedtime glucose < 300 mg/dL: A nudge-based quasi-experiment

    Mechanistic study

  19. Diabetes Res Clin Pract

    Associations of accelerometer-measured weekend sleep catch-up and loss with risk of type 2 diabetes: a prospective cohort study

    Cohort study

  20. Lancet Diabetes Endocrinol

    Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial

    Randomized controlled trial

  21. Diabetes Metab

    SGLT2 inhibitors and the risk of hepatocellular carcinoma in patients with MASLD and Type 2 diabetes

    Cohort study

  22. Diabetes Res Clin Pract

    Comparative effectiveness and prescribing patterns of dapagliflozin vs empagliflozin in type 2 diabetes patients: a target trial emulation

    Research article

  23. Diabetes Obes Metab

    Efficacy and safety of oral semaglutide in Chinese participants with type 2 diabetes: Subgroup analyses by baseline characteristics in the PIONEER 11 and 12 randomised controlled trials

    Secondary analysis

  24. Diabetes Obes Metab

    SGLT2 inhibitor therapy and lower incidence of iron deficiency anaemia in patients with type 2 diabetes: A retrospective cohort study from Germany

    Cohort study

  25. Diabetes Obes Metab

    Association between Chinese visceral adiposity index and heart failure in diabetic patients

    Cohort study

  26. Cardiovasc Diabetol

    Lipid metabolism-related inflammatory indices (LMIIs) and incident peripheral artery diseases (PAD) in patients with type 2 diabetes mellitus (T2DM): a multicohort study from China and the UK biobank

    Research article

  27. Diabetes Obes Metab

    Glycaemic responses to metformin monotherapy by SNP clusters in patients with type 2 diabetes

    Cohort study

  28. Diabetes Obes Metab

    Efficacy and safety of chiglitazar add‐on to metformin in type 2 diabetes mellitus ( RECAM study)

    Randomized controlled trial

  29. Cardiovasc Diabetol

    Effect of SGLT2 inhibitors on cardiac structure and function assessed by cardiac magnetic resonance: a systematic review and meta-analysis

    Meta-analysis

  30. Obesity (Silver Spring)

    Association of Glucagon‐Like Peptide‐1 Receptor Agonists With Cancer Risk in Older Adults With Type 2 Diabetes

    Cohort study

  31. Diabet Med

    Effectiveness of self‐management interventions on Type 2 diabetes among young adults (18–45 years): A systematic review and meta‐analysis

    Meta-analysis

  32. Cardiovasc Diabetol

    Comparative cardiovascular outcomes and safety of hypoglycemic drug classes in patients with type 2 diabetes and hypertension: a multicenter cohort analysis

    Cohort study

  33. Diabetes Obes Metab

    Cardiovascular disease risk estimates for primary prevention in the US prediabetes and diabetes population using the PREVENT equation

    Cross-sectional study

  34. Diabetes Res Clin Pract

    Association between SGLT2 inhibitor therapy and prolonged dementia-free survival in older adults with type 2 diabetes: a retrospective cohort study from Germany

    Cohort study

  35. Diabet Med

    Associations of glycaemia‐related risk factors with dementia and cognitive decline in individuals with type 2 diabetes: A systematic review and meta‐analysis

    Meta-analysis

  36. Diabetes Res Clin Pract

    Conversational agent interventions in diabetes care: a systematic review

    Meta-analysis

  37. Cardiovasc Diabetol

    Lipoprotein levels and statin treatment related to dementia and cognitive decline in individuals with type 2 diabetes: an observational analysis from the ADVANCE study

    Cohort study

  38. Diabetes Obes Metab

    Acidosis is associated with lower insulin sensitivity and incident type 2 diabetes in indigenous Americans: A prospective cohort study

    Cohort study

  39. Diabetes Obes Metab

    Comparison of subcutaneous, visceral, liver and muscle fat depots in relation to prevalent and incident diabetes

    Cohort study

  40. Diabetes Obes Metab

    Gender differences in the prescription of SGLT2 inhibitors in chronic kidney disease: A real‐world database study

    Cohort study

All 4,758 Briefs in ExploreShowing Briefs 1,361–1,400 of 4,758, newest first